Journal
ALLERGY AND ASTHMA PROCEEDINGS
Volume 28, Issue 2, Pages 226-229Publisher
OCEAN SIDE PUBLICATIONS INC
DOI: 10.2500/aap.2007.28.2950
Keywords
allergic rhinitis; clinical trial; cognitive function; continuous impairment; double blind; intranasal steroid; placebo controlled; seasonal allergic rhinitis; sleep disturbance; somnolence
Categories
Ask authors/readers for more resources
Patients with symptomatic allergic rhinitis often complain of daytime drowsiness and impairment in their speed of thinking responses. In this study, we compared subjects with allergic rhinitis treated with in tranasal fluticasone propionate or placebo. We measured nasal symptoms, daytime sleepiness, and cognitive performance. Total nasal symptoms (p = 0.002) and nasal congestion (p = 0.003) improved in the intranasal fluticasone propionate group. Concomitantly, daytime sleepiness decreased (p = 0.001) and cognitive performance improved (p = 0.02). The placebo-treated subjects did not show any significant changes. Effective therapy of allergic rhinitis ameliorates the symptoms of daytime sleepiness and decreased cognitive performance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available